Ambrx
A biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Learn more
Launch date
Employees
Market cap
€1.6b
Enterprise valuation
€1.4b (Public information from Feb 2024)
Share price
$28 AMAM
San Diego California (HQ)
Authorizing premium user...